Bosco

Revision as of 23:06, 1 January 2015 by Gordoben (talk | contribs) (Imported from Wikispaces)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

A single hyperbaric oxygen exposure preoperatively may modulate inflammatory markers and clinical complications following pancreatodudenectomy

Clinical Bottom Line:

    • 1. Some evidence that HBO exposure modulates the level IL-6 (down) and IL-10 (up)
    • 2. Fewer pulmonary complications with HBO exposure but not fistula development, bleeding or fever.
    • Citation/s: 1. Bosco G, Casarotto A, Nasole E, Camporesi E, Salvia R, Giovinazzo F, Zanini S, Malleo G, Di Tano A, Rubini A, Zanon V, Mangar D, Bassi C. Preconditioning with hyperbaric oxygen in pancreatodudenectomy: a randomised double-blind pilot study
    • Lead author's name and fax: Bosco G: gerardo.bosco@unipd.it; vincenzo.zanon@gmail.com
    • Three-part Clinical Question: Does preoperative hyperbaric oxygen exposure before pancreatoduodenectomy reduce the rate of postoperative complications?

Search Terms: Preconditioning; pancreatectomy; surgery

    • The Study: Double-blinded concealed randomised controlled trial with intention-to-treat.

The Study Patients: Adult patients scheduled for pancreatoduodenectomy for pancreatic ductal carcinoma.

    • Control group (N = 11; 11 analysed): A single sham exposure breathing air at 1.15 ATA on a schedule lasting 116 minutes on the day prior to surgery.
    • Experimental group (N = 10; 10 analysed): A single exposure to 2.5 ATA breathing 100% oxygen for a total of 116 minutes on the day prior to surgery.
    • The Evidence:
Outcome Time to Outcome Control group HBO group Relative Risk Reduction Absolute risk reduction NNT
Pulmonary complications ?Discharge 0.55 0 100% 0.55 2
^ 95% CI: 0.25 to 0.84 1 to 4
Postop bleeding ?Discharge 0.18 0.30 -65% -0.12 -8
^ 95% CI: -265% to 100% -0.48 to 0.25 NNT 4 to INF; NNH 2 to INF
Postop fistula ?Discharge 0.27 0.33 -22% -0.06 -17
^ 95% CI: -166% to 100% -0.45 to 0.33 NNT 3 to INF; NNH 2 to INF
Non-Event Outcomes Time to outcome/s Control group Experimental group P-value
Serum cytokine IL-6 (no units given) Pre-HBO/ Post-HBO/ Day 1 Postop/ Day 7 Postop 5.97/ 24.06/ 179.54 /24.5 5.06/ 5.81/ 141.23/ 21.76 0.009
Serum cytokine IL10 (no units given) Pre-HBO/ Post-HBO/ Day 1 Postop/ Day 7 Postop 4.04/ 4.43/ 7.76/ 4.14 2.01/ 2.41/ 5.6/ 3.34 0.034
    • Comments:

1. Small study underpowered for some outcomes.

2. There was a statistically significant relationship between IL-6 and post-operative fistula. Not clear if there is a causal relationship between serum IL-6 reduction and HBO, or between the development of fistula and serum IL-6 increase.

3. Reduction in post-operative pneumonia in HBO patients should be confirmed in larger studies

    • Appraised by: M. Bennett, POWH, m.bennett@unsw.edu.au; Friday, 2 January 2015

Kill or Update By: 01/012017

Sumhorsa.gif

BACK